The initial stages of CKD are characterized by a decreased ability to eliminate ingested phosphate, and this causes an increase in bone secretion of FGF23, which leads to phosphaturia, as the body attempts to maintain an appropriate level of phosphorus in the blood. This evidence concerns the gene FGF23 and chronic kidney disease.